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Background
Today there are various plasmid selection systems availa-
ble, whereas the most common approach comprises the
use of antibiotic resistance genes and the addition of the
corresponding drug into the medium. Bacterial vectors
carrying a ColE1-type origin, e.g. pBR322, the pET-series
[1] or the pUC-vectors are the most commonly used plas-
mids for recombinant protein production. For the appli-
cation of plasmid DNA in gene therapy or DNA
vaccination antibiotic resistance genes on the plasmid
backbone are highly unwanted. To avoid these resistance
genes and other additional sequences that can be used for
plasmid maintenance, we intend to exploit the plasmid
replication machinery in a novel plasmid addiction sys-
tem. The mechanism is based on RNA/RNA antisense
interaction involving the naturally occurring RNA I
derived from the plasmid's origin of replication (see Fig-
ure 1). The plasmid replicational regulatory network con-
sisting of RNA I/RNA II and their impact on Plasmid Copy
Number (PCN) was linked to the transcription of an reg-
ulatory target gene, present on the bacterial chromosome.
Consequently, the strategy presented in this work can be
applied for conventional protein expression vectors as
well as for therapeutical plasmids.
Results
In our experiments we found that RNA I was capable of
silencing engineered target genes by RNA antisense reac-
tion completely. On the mRNA transcript of the reporter
gene gfp (green fluorescent protein) RNA II-like sequences
were added near the ribosomal binding site. Thus, sup-
pression of a chromosomally inserted gfp gene could be
achieved by mere presence of the ColE1-type plasmid
pBR322 in shaker flask experiments and fed-batch fer-
mentation processes.
Conditionally lethal bacterial hosts were created by insert-
ing an inducible promoter on the genome in front of an
essential gene, e.g. murA [2] by homologous recombina-
tion [3]. By integration of an IPTG inducible expression
cassette on the bacterial genome containing the tet-repres-
sor gene (tetR), we were able to inhibit growth upon addi-
tion of IPTG, when the essential gene was set under
control of the corresponding promoter, pLtetO [4].
For the design of engineered hosts depending on a ColE1-
type plasmid in the cell the tetR transcript was combined
with RNA I complementary sequences. Thus, the plas-
mid's replication machinery provides an essential advan-
tage to the host cells.
Conclusion
Basically, the discrete reactions of the plasmid addiction
system were proven to be functional. We demonstrated
that the regulatory mechanism of ColE1 plasmid replica-
tion is a useful tool for gene silencing of a designed target
gene. Moreover, the essential gene murA was shown to be
an efficient target for the selection system.
The strategy of regulating gene expression by plasmid rep-
lication implicates a novel strategy for plasmid selection
in recombinant protein production processes and for gene
therapeutic applications.
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